1. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial with an optional Open-label Extension to evaluate the efficacy of bremelanotide (BMT), administered subcutaneously (SC) on an as needed basis for the treatment of HSDD (with or without decreased arousal) in premenopausal females.
Epistemonikos ID: 8ebb872dff3a5bd779fd742efbcbbe0b8844dec6
First added on: May 12, 2024